134 related articles for article (PubMed ID: 10321577)
1. A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors.
Bedard J; May S; Barbeau D; Yuen L; Rando RF; Bowlin TL
Antiviral Res; 1999 Feb; 41(1):35-43. PubMed ID: 10321577
[TBL] [Abstract][Full Text] [Related]
2. Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro.
Neyts J; Snoeck R; Balzarini J; De Clercq E
Antiviral Res; 1991 Jul; 16(1):41-52. PubMed ID: 1663729
[TBL] [Abstract][Full Text] [Related]
3. A rapid protein A binding radioimmunoassay for the evaluation of antiviral agents.
Gangopadhyay NN; Whitley RJ; Chatterjee S
J Virol Methods; 1994 Jul; 48(2-3):273-9. PubMed ID: 7527404
[TBL] [Abstract][Full Text] [Related]
4. Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo.
Stals FS; de Clercq E; Bruggeman CA
Antimicrob Agents Chemother; 1991 Nov; 35(11):2262-6. PubMed ID: 1666493
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
Neyts J; Snoeck R; Schols D; Balzarini J; De Clercq E
Virology; 1990 Nov; 179(1):41-50. PubMed ID: 2171213
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique.
Snoeck R; Schols D; Andrei G; Neyts J; De Clercq E
Antiviral Res; 1991 Jul; 16(1):1-9. PubMed ID: 1663725
[TBL] [Abstract][Full Text] [Related]
7. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication.
Snoeck R; Sakuma T; De Clercq E; Rosenberg I; Holy A
Antimicrob Agents Chemother; 1988 Dec; 32(12):1839-44. PubMed ID: 2854454
[TBL] [Abstract][Full Text] [Related]
8. Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro.
Shigeta S; Konno K; Baba M; Yokota T; De Clercq E
J Infect Dis; 1991 Feb; 163(2):270-5. PubMed ID: 1846389
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue.
Bidanset DJ; Rybak RJ; Hartline CB; Kern ER
Antiviral Res; 2004 Jul; 63(1):61-4. PubMed ID: 15196821
[TBL] [Abstract][Full Text] [Related]
10. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs.
Li SB; Yang ZH; Feng JS; Fong CK; Lucia HL; Hsiung GD
Antiviral Res; 1990 May; 13(5):237-52. PubMed ID: 2168690
[TBL] [Abstract][Full Text] [Related]
11. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
Neyts J; De Clercq E
Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
[TBL] [Abstract][Full Text] [Related]
12. Interpreting human cytomegalovirus antiviral drug susceptibility testing: the role of mixed virus populations.
Baldanti F; Biron KK; Gerna G
J Infect Dis; 1998 Mar; 177(3):823-4. PubMed ID: 9498475
[No Abstract] [Full Text] [Related]
13. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A
Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment of the host cell with 1-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) is sufficient for its antiviral effect.
Otová B; Votruba I; Holý A
Acta Virol; 1992 May; 36(3):313-9. PubMed ID: 1360759
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir.
Harada K; Eizuru Y; Isashiki Y; Ihara S; Minamishima Y
Arch Virol; 1997; 142(2):215-25. PubMed ID: 9125039
[TBL] [Abstract][Full Text] [Related]
16. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
Cihlar T; Fuller MD; Mulato AS; Cherrington JM
Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
[TBL] [Abstract][Full Text] [Related]
17. Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro.
van der Strate BW; De Boer FM; Bakker HI; Meijer DK; Molema G; Harmsen MC
Antiviral Res; 2003 Apr; 58(2):159-65. PubMed ID: 12742576
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro.
Snoeck R; Lagneaux L; Delforge A; Bron D; Van der Auwera P; Stryckmans P; Balzarini J; De Clercq E
Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):615-9. PubMed ID: 2170136
[TBL] [Abstract][Full Text] [Related]
19. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine against human cytomegalovirus when administered as single-bolus dose and continuous infusion in in vitro cell culture perfusion system.
Moore MR; Hamzeh FM; Lee FE; Lietman PS
Antimicrob Agents Chemother; 1994 Oct; 38(10):2404-8. PubMed ID: 7840578
[TBL] [Abstract][Full Text] [Related]
20. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
Williams-Aziz SL; Hartline CB; Harden EA; Daily SL; Prichard MN; Kushner NL; Beadle JR; Wan WB; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2005 Sep; 49(9):3724-33. PubMed ID: 16127046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
